Announcements

    Drinks

      DuPont Mobility & Materials-Celanese deal a blueprint for similar transactions in Europe
      MONDAY, 07/03/2022 - Scope Ratings GmbH
      Download PDF

      DuPont Mobility & Materials-Celanese deal a blueprint for similar transactions in Europe

      The acquisition of DuPont’s Mobility & Materials segment for USD 11bn is a big step forward for Celanese’s position in polymers and adds significant business diversification. It could be a blueprint for similar transactions in Europe.

      By Klaus Kobold, Associate Director, Corporate Ratings

      This latest deal follows similar transactions in the sector. In 2020, BASF acquired Solvay’s polyamide business while Arkema sold its PMMA business to Trinseo. In 2019, Evonik Industries offloaded its PMMA division to private equity firm Advent International. These transactions were pursued to allow the acquirers to upgrade and realign their portfolios but also to respond, more importantly, to ESG-related topics. Only a limited amount of plastic is recycled, around 35% in the EU; around 8% in the US.

      Dupont aims to become a leading player in chemicals products for electronics, water, industrial technologies, protection and Next Generation automotive. Last year, it expanded its portfolio by acquiring Laird Performance Materials. It also intends to acquire Rogers Corporation. As for the business it is now selling to Celanese, sales in 2021 were roughly USD 3.5bn and operating EBITDA was USD 800m. The business is centred around engineered polymers, resins and elastomers. Celanese will acquire a family of nylon products, high-performance polyesters, and various elastomers. The products have application in the automotive, consumer and multiple industrial markets.

      Following the sale of DSM’s Resins and Functional Materials division to Covestro in April 2021, DSM intends to sell the remainder of its materials division to become a pure nutrients and life-science company. LANXESS (BBB+/Stable) may push in the same direction, since it executed two large acquisitions in its Consumer Protection division in 2021: Emerald Kalama Chemical and IFF Microbial Control business unit).

      On the basis of the size of these businesses (DSM Materials 2021 revenue: EUR 1.9bn; LANXESS: Engineered Materials 2020: EUR 1.2bn), it would give additional firepower to push ambitions forward, or in the case of LANXESS, an ability for accelerated deleveraging.

      Access all Scope rating & research reports on ScopeOne, Scope’s digital marketplace, which includes API solutions such as for Credit Sphere.

      Related news

      Show all
      Scope downgrades GTC’s issuer rating to B+ from BB+, places it under review for a developing outcome

      11/6/2025 Rating announcement

      Scope downgrades GTC’s issuer rating to B+ from BB+, places ...

      Scope affirms BB-/Stable issuer rating of real estate and financial broker Duna House

      11/6/2025 Rating announcement

      Scope affirms BB-/Stable issuer rating of real estate and ...

      Scope upgrades issuer rating of Vend Marketplaces ASA to BBB+ with Stable Outlook

      11/6/2025 Rating announcement

      Scope upgrades issuer rating of Vend Marketplaces ASA to BBB+ ...

      Tariffs, EV transition, tighter margins test resilience in Europe’s auto sector

      10/6/2025 Research

      Tariffs, EV transition, tighter margins test resilience in ...

      Scope affirms B+/Stable issuer rating on Hungarian investment holding Lexholding Zrt.

      6/6/2025 Rating announcement

      Scope affirms B+/Stable issuer rating on Hungarian investment ...

      Scope assigns first-time issuer rating of B+/Stable to Georgia Healthcare Group

      6/6/2025 Rating announcement

      Scope assigns first-time issuer rating of B+/Stable to ...